In this systematic review and meta-analysis, researchers examined outcomes among advanced ovarian cancer patients who ...

Fuzuloparib monotherapy significantly improved PFS in advanced ovarian cancer, but adding apatinib did not enhance outcomes. The study included patients with newly diagnosed ovarian, fallopian tube, ...

A retrospective study compared progression-free and overall survival of hyperthermic intraperitoneal chemotherapy with conventional intraperitoneal chemotherapy in patients with ovarian cancer.

Liu described the CAR-like T cells as cytokine-activated lymphocytes engineered with the tumor-targeting and -penetrating ...

Though the findings are positive overall, survival increases since the mid-1990s are especially notable for more fatal ...

The five-year survival rate for all cancers combined in the US reached a landmark 70% for Americans diagnosed between 2015 ...

An annual report from the American Cancer Society shows that, for the first time, over 70% of Americans diagnosed with cancer ...

For the first time ever, the five-year survival rate for all cancers combined has reached 70 percent. While it's a moment to ...

A new report shows the five-year survival rate for all cancers reached a historic 70%. About 2.1 million new cancer diagnoses ...

Lung cancer incidence rates in the United States have undergone a significant transformation over the last several decades, ...

Cancer survival in the U.S. has climbed to 70%, reflecting major advances in treatment, early detection and personalized care ...